Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd (NASDAQ: CLBT) provides authoritative digital intelligence solutions to law enforcement and enterprises worldwide. This news hub offers investors and professionals a centralized resource for tracking corporate developments, technological advancements, and strategic initiatives shaping the digital forensics sector.
Access timely updates including earnings reports, product launches, partnership announcements, and regulatory filings. Our curated collection ensures stakeholders stay informed about critical developments affecting investigative technology markets, cybersecurity trends, and Cellebrite’s position as a leader in legally sanctioned data analysis solutions.
Key updates cover innovations in mobile device forensics, cloud data extraction tools, and enterprise-grade investigative platforms. Regular monitoring of this page provides insights into Cellebrite’s subscription revenue growth, global expansion efforts, and responses to evolving data privacy regulations.
Bookmark this page for structured access to CLBT’s official communications and third-party analysis. Combine technical understanding of digital intelligence markets with strategic business insights through our maintained news archive.
Cellebrite (NASDAQ: CLBT) reported strong Q4 2024 results with revenue of $109.0 million, up 17% year-over-year, driven by 21% growth in subscription revenue. The company achieved Annual Recurring Revenue (ARR) of $395.9 million, up 25% year-over-year, with a recurring revenue dollar-based net retention rate of 124%.
Q4 2024 highlights include GAAP net income of $19.3 million, non-GAAP net income of $26.1 million, and adjusted EBITDA of $28.8 million with a 26.4% margin. For full-year 2024, revenue reached $401.2 million, up 23% year-over-year, with subscription revenue of $353.0 million, up 26%.
The company provided 2025 guidance projecting ARR between $480-495 million (21-25% growth) and revenue of $480-490 million (20-22% growth). Cellebrite achieved a 'Rule of 50' performance in 2024 with 25% ARR growth and 25% adjusted EBITDA margin.
Cellebrite (NASDAQ: CLBT) announced that its Cellebrite Government Cloud platform has achieved FedRAMP High Ready designation by the Federal Risk and Authorization Management Program. This milestone represents the initial stage in the compliance process, demonstrating the company's commitment to providing U.S. federal customers with high-level cloud security for their digital investigative solutions.
The platform underwent review by a Third-Party Assessment Organization and received approval through a Readiness Assessment Report from the FedRAMP Program Management Office. Cellebrite is working with Coalfire, a cybersecurity services leader, and Amazon Web Services (AWS) for this initiative.
Initially, the Government Cloud will support Cellebrite Inseyets, the company's digital forensics solution, with plans to expand to include Cellebrite Guardian, their cloud solution for digital evidence sharing, review, and management.
Cellebrite (NASDAQ: CLBT) has released its sixth annual Industry Trends Survey for 2025, gathering insights from over 2,100 professionals across 100 countries in the digital investigation field. The survey reveals significant trends in digital evidence and investigation technologies:
Key findings include:
- 80% of respondents acknowledge AI's role in automating tasks and accelerating evidence identification
- 98% of prosecutors confirm digital evidence's important role in securing convictions
- 40% of professionals are now open to cloud-based solutions for evidence storage, up from 35% last year
- 69% of investigative teams report lacking adequate tools and time to review case data
The survey highlights that while 30% of respondents have observed increased AI-related criminal activity, 64% believe AI can help reduce crime. Cases typically involve 2-5 devices, with data volumes doubling over the past two years. Despite cloud solutions' growing adoption, 60% of investigators still rely on legacy methods like USB drives for data sharing.
Cellebrite (NASDAQ: CLBT) announced the general availability of Generative AI (GenAI) capabilities within Guardian, its SaaS-based evidence management solution. The new features help public safety agencies process digital evidence more efficiently by:
- Summarizing chat threads from smartphones containing an average of 60,000 text messages
- Providing relationship insights for investigating complex crime networks
- Analyzing browsing history by breaking down complex URLs and contextualizing searches
Detective Sergeant Aaron Osman from Susquehanna Township Police Department reported that the GenAI capabilities helped translate and summarize chats between suspects, leading to the discovery of an international organized crime ring involved in porch package thefts. According to Cellebrite's industry survey, while 30% of respondents noticed increased AI-related criminal activity, 64% believe AI technology can help reduce crime.
Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative solutions, has announced it will release its fourth-quarter and fiscal year 2024 financial results before market open on Thursday, February 13, 2025.
The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the Q4 2024 results and provide outlook for 2025. Historical financial tables and supplemental data will be made available on the company's investor relations website.
Cellebrite (NASDAQ: CLBT), a global leader in digital investigative solutions, has announced its participation in the upcoming Needham & Company 27th Annual Growth Conference.
The event will take place on January 14, 2025, with Cellebrite's presentation scheduled for 8:45 a.m. ET. The presentation format will be a Fireside Chat and can be accessed via the event URL: https://investors.cellebrite.com/events/event-details/needham-co-27th-annual-growth-conference.
Key executives representing Cellebrite at the conference will be Dana Gerner, Chief Financial Officer, and Andrew Kramer, Vice President, Investor Relations.
Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative solutions, announced key updates to its Board of Directors to bolster the company's growth in 2025 and beyond. As of January 1, 2025, Thomas E. Hogan has been confirmed as interim CEO, while maintaining his role on the Board, with plans to revert to chairman once a new CEO is appointed. Adam H. Clammer, Managing Partner of True Wind Capital Management, has taken on the role of board chairman, adhering to best practices in board governance by separating the CEO and board chair duties.
Additionally, Michael D. Capellas, with extensive leadership experience across top technology companies, joins Cellebrite's Board as a Class II director and the new lead independent director, replacing Adam Clammer. Capellas's notable roles include CEO positions at VCE, First Data , MCI, Compaq Computer , and President at Hewlett-Packard.
Capellas expressed enthusiasm for joining Cellebrite, highlighting his commitment to justice, safety, and security, and his alignment with the company's mission to combat child exploitation and trafficking.
D-Fend Solutions has secured $31M in a new investment round led by Israel Growth Partners (IGP), with participation from Vertex Ventures and Vertex Growth. The company, specializing in RF cyber-based counter-drone technology, reported over 60% year-over-year revenue growth and expansion across nearly 30 countries, including Five Eyes alliance, G7, and NATO member states.
The funding will support technological advancement, market expansion, and addressing evolving drone threats. D-Fend's flagship product, EnforceAir, uses RF cyber-takeover techniques to neutralize rogue drones safely without operational disruption. The technology has been recognized by Booz Allen Hamilton and is deployed to protect military zones, airports, critical infrastructure, prisons, and public events.
Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative solutions, announced its participation in the upcoming UBS Global Technology and AI Conference. The company will participate in a fireside chat on December 3, 2024, at 4:55 p.m. ET. Key executives attending include Thomas Hogan (executive chairman), Dana Gerner (CFO), and Andrew Kramer (VP of investor relations).
Cellebrite (Nasdaq: CLBT) and Relativity announced the general availability of Cellebrite's mobile collection solutions integration into RelativityOne platform. The integration enables faster and more efficient mobile data management in legal processes. Following a successful Advanced Access program in July 2024, users reported significant efficiency gains, reducing mobile device data collection time to just over an hour compared to previous days or weeks. The integration allows remote mobile device collections to be fully orchestrated within RelativityOne, including custodian notification and automatic data transfer. According to Cellebrite's 2024 Industry Trends survey, 97% of eDiscovery cases now involve at least one mobile device.
FAQ
What is the current stock price of Cellebrite Di (CLBT)?
What is the market cap of Cellebrite Di (CLBT)?
